19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Circadian disruption promotes tumor growth by anabolic host metabolism; experimental evidence in a rat model

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Light at night creates a conflicting signal to the biological clock and disrupts circadian physiology. In rodents, light at night increases the risk to develop mood disorders, overweight, disrupted energy metabolism, immune dysfunction and cancer. We hypothesized that constant light (LL) in rats may facilitate tumor growth via disrupted metabolism and increased inflammatory response in the host, inducing a propitious microenvironment for tumor cells.

          Methods

          Male Wistar rats were exposed to LL or a regular light-dark cycle (LD) for 5 weeks. Body weight gain, food consumption, triglycerides and glucose blood levels were evaluated; a glucose tolerance test was also performed. Inflammation and sickness behavior were evaluated after the administration of intravenous lipopolysaccharide. Tumors were induced by subcutaneous inoculation of glioma cells (C6). In tumor-bearing rats, the metabolic state and immune cells infiltration to the tumor was investigated by using immunohistochemistry and flow cytometry. The mRNA expression of genes involved metabolic, growth, angiogenes and inflammatory pathways was measured in the tumor microenvironment by qPCR. Tumor growth was also evaluated in animals fed with a high sugar diet.

          Results

          We found that LL induced overweight, high plasma triglycerides and glucose levels as well as reduced glucose clearance. In response to an LPS challenge, LL rats responded with higher pro-inflammatory cytokines and exacerbated sickness behavior. Tumor cell inoculation resulted in increased tumor volume in LL as compared with LD rats, associated with high blood glucose levels and decreased triglycerides levels in the host. More macrophages were recruited in the LL tumor and the microenvironment was characterized by upregulation of genes involved in lipogenesis ( Acaca, Fasn, and Pparγ), glucose uptake ( Glut-1), and tumor growth ( Vegfα, Myc, Ir) suggesting that LL tumors rely on these processes in order to support their enhanced growth. Genes related with the inflammatory state in the tumor microenvironment were not different between LL and LD conditions. In rats fed a high caloric diet tumor growth was similar to LL conditions.

          Conclusions

          Data indicates that circadian disruption by LL provides a favorable condition for tumor growth by promoting an anabolic metabolism in the host.

          Electronic supplementary material

          The online version of this article (10.1186/s12885-017-3636-3) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Distinct role of macrophages in different tumor microenvironments.

          Macrophages are prominent in the stromal compartment of virtually all types of malignancy. These highly versatile cells respond to the presence of stimuli in different parts of tumors with the release of a distinct repertoire of growth factors, cytokines, chemokines, and enzymes that regulate tumor growth, angiogenesis, invasion, and/or metastasis. The distinct microenvironments where tumor-associated macrophages (TAM) act include areas of invasion where TAMs promote cancer cell motility, stromal and perivascular areas where TAMs promote metastasis, and avascular and perinecrotic areas where hypoxic TAMs stimulate angiogenesis. This review will discuss the evidence for differential regulation of TAMs in these microenvironments and provide an overview of current attempts to target or use TAMs for therapeutic purposes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc.

            Unlike normal mammalian cells, which use oxygen to generate energy, cancer cells rely on glycolysis for energy and are therefore less dependent on oxygen. We previously observed that the c-Myc oncogenic transcription factor regulates lactate dehydrogenase A and induces lactate overproduction. We, therefore, sought to determine whether c-Myc controls other genes regulating glucose metabolism. In Rat1a fibroblasts and murine livers overexpressing c-Myc, the mRNA levels of the glucose transporter GLUT1, phosphoglucose isomerase, phosphofructokinase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and enolase were elevated. c-Myc directly transactivates genes encoding GLUT1, phosphofructokinase, and enolase and increases glucose uptake in Rat1 fibroblasts. Nuclear run-on studies confirmed that the GLUT1 transcriptional rate is elevated by c-Myc. Our findings suggest that overexpression of the c-Myc oncoprotein deregulates glycolysis through the activation of several components of the glucose metabolic pathway.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Versatile functions for IL-6 in metabolism and cancer.

              Owing to its abundance in inflammatory settings, interleukin IL-6 is frequently viewed as a proinflammatory cytokine, with functions that parallel those of tumor necrosis factor (TNF) and IL-1β in the context of inflammation. However, accumulating evidence points to a broader role for IL-6 in a variety of (patho)physiological conditions, including functions related to the resolution of inflammation. We review recent findings on the complex biological functions governed by IL-6 signaling, focusing on its role in inflammation-associated cancer and metabolic disorders such as obesity and type 2 diabetes mellitus (T2DM). We propose that the anti-inflammatory functions of IL-6 may extend to multiple settings and cell types, and suggest that these dimensions should be incorporated in therapeutic approaches to these diseases. Finally, we outline important areas of inquiry towards understanding this pleiotropic cytokine.
                Bookmark

                Author and article information

                Contributors
                natalinadi@yahoo.com.mx
                rasane18@gmail.com
                marda1808@gmail.com
                mcbasualdo@yahoo.com
                estefaneb@hotmail.com
                ana_lopez_bago@hotmail.com
                rlascurainl@yahoo.com.mx
                ruudbuijs@gmail.com
                escocarolina@gmail.com
                Journal
                BMC Cancer
                BMC Cancer
                BMC Cancer
                BioMed Central (London )
                1471-2407
                6 September 2017
                6 September 2017
                2017
                : 17
                : 625
                Affiliations
                [1 ]ISNI 0000 0001 2159 0001, GRID grid.9486.3, Departamento de Anatomía, Facultad de Medicina, UNAM, , Universidad Nacional Autónoma de México, ; Ciudad Universitaria, 04510 México City, Mexico
                [2 ]ISNI 0000 0001 2159 0001, GRID grid.9486.3, Departamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, , Universidad Nacional Autónoma de México, ; 04510 Mexico City, CP Mexico
                [3 ]ISNI 0000 0001 2159 0001, GRID grid.9486.3, Departamento de Bioquímica, Facultad de Medicina, , Universidad Nacional Autónoma de México, ; 04510 Mexico City, CP Mexico
                [4 ]ISNI 0000 0001 2159 0001, GRID grid.9486.3, Departamento de Medicina experimental, Facultad de Medicina, , Universidad Nacional Autónoma de México, ; 04510 Mexico City, Mexico
                Author information
                http://orcid.org/0000-0002-2974-7875
                Article
                3636
                10.1186/s12885-017-3636-3
                5585981
                28874144
                1a04e103-f45f-4a27-b086-a3fc2712f576
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 2 April 2017
                : 28 August 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100003141, Consejo Nacional de Ciencia y Tecnología;
                Award ID: 239403
                Award ID: Nr220598
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100006087, Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México;
                Award ID: Postdoctoral fellowship
                Award Recipient :
                Funded by: Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica- UNAM
                Award ID: IG200314
                Award Recipient :
                Funded by: Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica-UNAM
                Award ID: IG200314
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2017

                Oncology & Radiotherapy
                light at night,circadian disruption,tumor development,inflammation,metabolism and obesity

                Comments

                Comment on this article